RecruitingNCT05963061
Chronic Myeloid Leukemia (CML) Real-Life Database
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
3,500 participants
Start Date
Apr 16, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.
Eligibility
Inclusion Criteria1
- Patient diagnosed for chronic myelocytic leukemia
Exclusion Criteria2
- CML allograft without TKI treatment
- Refusal or inability to sign the consent
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05963061